Centre for Social Research in Health, UNSW Sydney, Sydney, New South Wales, Australia.
The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Addiction. 2023 Jun;118(6):1153-1160. doi: 10.1111/add.16137. Epub 2023 Feb 12.
Hepatitis C virus (HCV) is highly prevalent within the prison setting. Although HCV testing and treatment are available within prisons, system barriers can impede progress along the HCV care cascade for those who are incarcerated. The PIVOT intervention used a 'one-stop-shop' model (i.e. point-of-care HCV RNA testing, Fibroscan-based liver disease assessment and treatment) at a reception prison in New South Wales, Australia. This analysis sought to understand the role of point-of-care HCV RNA testing at intake in reducing barriers to the HCV care cascade within the male prison setting.
Qualitative analysis using semi-structured interviews in a reception prison in Australia.
Twenty-four men enrolled in the PIVOT study; all participants had undergone HCV point-of-care testing in the intervention arm.
Høj's Integrated Framework informed this analysis.
Participants widely expressed the view that point-of-care HCV RNA testing on entry was beneficial for care engagement. Point-of-care testing was perceived as timely (compared with standard pathology) and reduced opportunities for adjudication by correctional officers due to fewer clinic visits for testing and results. Adoption of routine opt-out testing at prison intake was regarded as an important strategy for normalising HCV testing (and likely to increase pathways to treatment uptake) and fostered patient candidacy (i.e. self-perceived eligibility to access care).
Twenty-four men in prison in New South Wales, Australia, who underwent opt-out point-of-care HCV RNA testing on entry into prison, widely supported the programme as a means of overcoming barriers to HCV testing and treatment in the prison setting, as well as providing public health benefits through early detection of HCV infection among people entering into custody.
丙型肝炎病毒(HCV)在监狱环境中高度流行。尽管监狱内提供 HCV 检测和治疗,但系统障碍可能会阻碍那些被监禁的人沿着 HCV 护理级联前进。PIVOT 干预措施在澳大利亚新南威尔士州的一所收押监狱采用了“一站式”模式(即即时 HCV RNA 检测、基于 Fibroscan 的肝脏疾病评估和治疗)。本分析旨在了解在收押监狱进行即时 HCV RNA 检测在减少男性监狱环境中 HCV 护理级联障碍方面的作用。
在澳大利亚一所收押监狱进行定性分析,采用半结构化访谈。
24 名参加 PIVOT 研究的男性;所有参与者在干预组中都接受了 HCV 即时检测。
Høj 的综合框架指导了这项分析。
参与者普遍认为,进入时进行即时 HCV RNA 检测有助于护理参与。即时检测被认为是及时的(与标准病理学相比),并减少了狱警裁决的机会,因为减少了为检测和结果进行的诊所就诊次数。在监狱入院时采用常规的默认检测被认为是一种重要的策略,可以使 HCV 检测正常化(可能会增加接受治疗的途径),并促进患者的候选资格(即自我认为有资格获得护理)。
澳大利亚新南威尔士州的 24 名入狱男性在进入监狱时接受了默认的即时 HCV RNA 检测,他们广泛支持该计划,认为这是克服监狱环境中 HCV 检测和治疗障碍的一种手段,并且通过在进入拘留的人群中早期检测 HCV 感染,为公共卫生带来了益处。